SUNBEAM phase 3 trial for relapsing MS launched

[MSUK]

Biopharmaceutical company Receptos, Inc. has enrolled the first participant with relapsing multiple sclerosis (RMS) in its SUNBEAM phase 3 trial, which will evaluate the potential therapy RPC1063 in patients who suffer from the disease. The company’s phase 3 RADIANCE trial, also involving RMS patients, had already been initiated, which means that Receptos may be able to finish its clinical development program for multiple sclerosis by 2017, according to the company’s press release......... Read More - http://www.ms-uk.org/RPC1063

[cheerleader]

oh, the irony. A sphingosine 1-phosphate 1 and 5 receptor modulator drug trial called "sunbeam."
http://ir.receptos.com/releasedetail.cf ... eid=888647

Meanwhile, the sun's free UV rays have been shown to modulate and calm inflammation and over-active auto-immunity in MS.
http://www.ncbi.nlm.nih.gov/pubmed/24771567
http://www.pnas.org/content/107/14/6418
http://www.jacionline.org/article/S0091-6749(12%2900402-2/abstract
http://ccsviinms.blogspot.com/2014/04/m ... mptom.html

cheer

[1eye]

How is RMS different from RRMS, PPMS, and SPMS? Who decides these monikers?